Stay updated with breaking news from Ray Gordon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conferences in November: Stifel 2022 Healthcare Conference Date: Tuesday, Nov. 15
-- Month 12 results from MIRROR randomized controlled trial to be featured on Nov. 13, 11:45 a.m. EST during plenary session at the American College of Rheumatology Convergence 2022 -- -- Imaging
-- MIRROR randomized controlled trial data to be presented during Kidney Week 2022 show consistent kidney function, eGFR levels, for people receiving KRYSTEXXA with methotrexate throughout the treatment
Third-Quarter 2022 Results: -- Net Sales of $925.4 Million -- -- GAAP Net Income of $135.8 Million; Adjusted EBITDA of $335.3 Million, Which Includes $19.0 Million of Acquired IPR&D and Milestones
--Company Recognized for Transparency and Best Practices Related to an Inclusive Culture-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced it has been named to Seramount's (formerly Working